Crescent Capital BDC, Inc. (NASDAQ:CCAP) Receives Average Rating of “Hold” from Brokerages

Crescent Capital BDC, Inc. (NASDAQ:CCAP) has been given a consensus rating of “Hold” by the six research firms that are currently covering the stock, Marketbeat reports. Four research analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 1-year target price among analysts that have updated their coverage on the stock in the last year is $13.30.

Several research firms recently commented on CCAP. Zacks Research upgraded shares of Crescent Capital BDC from a “strong sell” rating to a “hold” rating in a research report on Tuesday, July 21st. Oppenheimer downgraded shares of Crescent Capital BDC from an “outperform” rating to a “market perform” rating and decreased their price objective for the stock from $19.00 to $16.00 in a research report on Friday, May 15th. Keefe, Bruyette & Woods lowered their target price on shares of Crescent Capital BDC from $15.00 to $13.00 and set an “outperform” rating on the stock in a research note on Tuesday, June 16th. Wells Fargo & Company dropped their target price on Crescent Capital BDC from $12.00 to $11.00 and set an “equal weight” rating on the stock in a research report on Wednesday. Finally, Wall Street Zen lowered Crescent Capital BDC from a “hold” rating to a “sell” rating in a research note on Saturday, July 25th.

Insider Activity at Crescent Capital BDC

In other Crescent Capital BDC news, CEO Jason Breaux acquired 5,000 shares of the business’s stock in a transaction dated Wednesday, May 20th. The stock was acquired at an average cost of $11.19 per share, for a total transaction of $55,950.00. Following the completion of the transaction, the chief executive officer directly owned 52,636 shares of the company’s stock, valued at $588,996.84. This represents a 10.50% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, President Henry Chung bought 4,500 shares of Crescent Capital BDC stock in a transaction dated Thursday, May 21st. The shares were acquired at an average cost of $11.45 per share, with a total value of $51,525.00. Following the completion of the purchase, the president owned 20,722 shares in the company, valued at approximately $237,266.90. This trade represents a 27.74% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. 1.23% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Crescent Capital BDC

Several hedge funds and other institutional investors have recently added to or reduced their stakes in CCAP. Fidelity National Financial Inc. purchased a new stake in shares of Crescent Capital BDC during the second quarter worth about $45,922,000. North Ground Capital lifted its stake in Crescent Capital BDC by 99.8% in the 4th quarter. North Ground Capital now owns 835,312 shares of the company’s stock valued at $11,736,000 after buying an additional 417,312 shares in the last quarter. Invesco Ltd. lifted its stake in Crescent Capital BDC by 1,504.9% in the 4th quarter. Invesco Ltd. now owns 659,696 shares of the company’s stock valued at $9,269,000 after buying an additional 618,590 shares in the last quarter. Franklin Resources Inc. boosted its holdings in Crescent Capital BDC by 7.0% in the 3rd quarter. Franklin Resources Inc. now owns 540,460 shares of the company’s stock worth $7,707,000 after buying an additional 35,534 shares during the last quarter. Finally, Bulldog Investors LLP boosted its holdings in Crescent Capital BDC by 4.6% in the 4th quarter. Bulldog Investors LLP now owns 457,518 shares of the company’s stock worth $6,428,000 after buying an additional 20,000 shares during the last quarter. 49.46% of the stock is owned by hedge funds and other institutional investors.

Crescent Capital BDC Price Performance

Shares of NASDAQ CCAP opened at $11.08 on Thursday. The stock has a market capitalization of $408.30 million, a price-to-earnings ratio of -123.11 and a beta of 0.52. Crescent Capital BDC has a 12 month low of $10.64 and a 12 month high of $16.03. The firm’s 50 day simple moving average is $11.16 and its 200-day simple moving average is $12.36. The company has a debt-to-equity ratio of 1.35, a current ratio of 1.53 and a quick ratio of 1.53.

Crescent Capital BDC (NASDAQ:CCAP) last posted its earnings results on Monday, August 10th. The company reported $0.36 earnings per share for the quarter, missing the consensus estimate of $0.37 by ($0.01). Crescent Capital BDC had a negative net margin of 2.02% and a positive return on equity of 8.88%. The firm had revenue of $5.12 million for the quarter, compared to analysts’ expectations of $37.12 million. Analysts expect that Crescent Capital BDC will post 1.38 EPS for the current year.

Crescent Capital BDC Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, October 15th. Shareholders of record on Wednesday, September 30th will be issued a $0.34 dividend. This represents a $1.36 annualized dividend and a yield of 12.3%. The ex-dividend date of this dividend is Wednesday, September 30th. Crescent Capital BDC’s dividend payout ratio (DPR) is presently -1,511.11%.

Key Headlines Impacting Crescent Capital BDC

Here are the key news stories impacting Crescent Capital BDC this week:

• Positive Sentiment: Crescent maintained its quarterly base dividend at $0.34 per share and declared an additional $0.03 special dividend. The base dividend equates to an annualized yield of approximately 11.9% at the referenced share price, supporting the stock’s income appeal. Crescent Capital BDC Q2 2026 earnings and dividend announcement
• Positive Sentiment: Management expects leverage to return to its target range during the second half of 2026 while continuing the $0.34 dividend. Improved balance-sheet positioning could support future earnings and distribution stability. Crescent Capital BDC leverage outlook
• Neutral Sentiment: Ladenburg Thalmann lowered its price target from $15 to $14 but retained a Buy rating, implying substantial upside from the referenced price. The target reduction nevertheless signals more cautious valuation expectations. Benzinga analyst action
• Negative Sentiment: Wells Fargo cut its target from $12 to $11 and maintained an Equal Weight rating, indicating limited near-term upside and adding pressure to the shares. The Fly analyst action
• Negative Sentiment: Second-quarter earnings modestly missed consensus, with earnings per share of $0.36 versus the $0.37 estimate. The miss likely contributed to investor caution despite the dividend declarations and leverage guidance. Crescent Capital BDC second-quarter earnings results

Crescent Capital BDC Company Profile

Crescent Capital BDC, Inc is a closed-end, externally managed business development company that provides flexible financing solutions to middle market companies in the United States. Trading on the Nasdaq under the ticker CCAP, the firm offers investors exposure to a diversified portfolio of debt and equity instruments, targeting businesses with attractive risk-adjusted return profiles. Its primary objective is to generate current income through interest payments and potential capital appreciation via selective equity co-investments.

The company’s investment strategy emphasizes senior secured loans, unsecured second-lien loans, mezzanine debt, as well as preferred and common equity co-investments.